Publications by authors named "David Carlander"

Claim this Profile
M
Mammalian gastrointestinal tract parameters modulating the integrity, surface properties, and absorption of food-relevant nanomaterials.
Susann Bellmann, David Carlander, Alessio Fasano, Dragan Momcilovic, Joseph A Scimeca

Wiley Interdiscip Rev Nanomed Nanobiotechnol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurement Methods to Evaluate Engineered Nanomaterial Release from Food Contact Materials.
Gregory O Noonan, Andrew J Whelton, David Carlander, Timothy V Duncan

Compr Rev Food Sci Food Saf· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurement Methods to Detect, Characterize, and Quantify Engineered Nanomaterials in Foods.
Gurmit Singh, Chady Stephan, Paul Westerhoff, David Carlander, Timothy V Duncan

Compr Rev Food Sci Food Saf· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurement Methods for the Oral Uptake of Engineered Nanomaterials from Human Dietary Sources: Summary and Outlook.
Christopher Szakal, Lyubov Tsytsikova, David Carlander, Timothy V Duncan

Compr Rev Food Sci Food Saf· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methods to Evaluate Uptake of Engineered Nanomaterials by the Alimentary Tract.
Heather Alger, Dragan Momcilovic, David Carlander, Timothy V Duncan

Compr Rev Food Sci Food Saf· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of abdominal fat and incipient metabolic syndrome in young healthy men exposed to long-term stress.
Stefan Branth, Gunnar Ronquist, Mats Stridsberg, Leif Hambraeus, Erik Kindgren, David Carlander

Nutr Metab Cardiovasc Dis· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
More than 10 years' continuous oral treatment with specific immunoglobulin Y for the prevention of Pseudomonas aeruginosa infections: a case report.
Elin Nilsson, Hans Kollberg, Marie Johannesson, Per-Erik Wejåker, David Carlander

J Med Food· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral immunotherapy with yolk antibodies to prevent infections in humans and animals.
Anders Larsson, David Carlander

Ups J Med Sci· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retention of specific yolk IgY in the human oral cavity.
David Carlander, Hans Kollberg, Anders Larsson

BioDrugs· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral administration of specific yolk antibodies (IgY) may prevent Pseudomonas aeruginosa infections in patients with cystic fibrosis: a phase I feasibility study.
Hans Kollberg, David Carlander, Hanne Olesen, Per-Erik Wejåker, Marie Johannesson

Pediatr Pulmonol· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis